Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children
Open Access
- 1 January 2014
- journal article
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 3 (1) , 91-99
Abstract
Cha SH, et al. Clin Exp Vaccine Res. 2014 Jan;3(1):91-99. https://doi.org/10.7774/cevr.2014.3.1.91Keywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 28 references indexed in Scilit:
- Immunogenicity and safety of a measles–mumps–rubella–varicella vaccine following a 4-week or a 12-month interval between two dosesVaccine, 2011
- Surveillance and Control of Rubella in the Republic of Korea From 2001 to 2009: The Necessity for Enhanced Surveillance to Monitor Congenital Rubella SyndromeOsong Public Health and Research Perspectives, 2010
- Seroprevalence of varicella‐zoster virus in KoreaJournal of Medical Virology, 2010
- Reappraisal of MMR vaccines currently used in KoreaPediatrics International, 2010
- Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care settingVaccine, 2009
- Immunogenicity and Safety Assessments After One and Two Doses of a Refrigerator-Stable Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children During the Second Year of LifeThe Pediatric Infectious Disease Journal, 2008
- Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in EuropeThe Pediatric Infectious Disease Journal, 2007
- Immunogenicity and Safety of a Second Dose of Measles???Mumps???Rubella???Varicella Vaccine in Healthy Children Aged 5 to 6 YearsThe Pediatric Infectious Disease Journal, 2007
- Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy ChildrenThe Pediatric Infectious Disease Journal, 2005
- Consensus: Varicella Vaccination of Healthy ChildrenThe Pediatric Infectious Disease Journal, 2004